Mycophenolate mofetil Terminated Phase 3 Trials for Transplantation, Kidney / Cardiovascular Disease (CVD) Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01213394Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients